Literature DB >> 20132714

Stevens-Johnson syndrome secondary to oseltamivir (Tamiflu).

Emma Victoria Smith, Michael Charles Pynn, Sharon Blackford, David J Leopold.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20132714      PMCID： PMC2814276          DOI： 10.3399/bjgp10X483292

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  2 in total

Review 1.  Neuraminidase inhibitors for preventing and treating influenza in healthy adults.

Authors:  T O Jefferson; V Demicheli; C Di Pietrantonj; M Jones; D Rivetti
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

Review 2.  Systematic review: safety and efficacy of extended-duration antiviral chemoprophylaxis against pandemic and seasonal influenza.

Authors:  Nayer Khazeni; Dena M Bravata; Jon-Erik C Holty; Timothy M Uyeki; Christopher D Stave; Michael K Gould
Journal:  Ann Intern Med       Date:  2009-08-03       Impact factor: 25.391
  2 in total
  3 in total

Review 1.  Stevens - Johnson Syndrome and Toxic Epidermal Necrolysis; Extensive Review of Reports of Drug-Induced Etiologies, and Possible Therapeutic Modalities.

Authors:  Adegbenro Omotuyi John Fakoya; Princess Omenyi; Precious Anthony; Favour Anthony; Precious Etti; David Adeiza Otohinoyi; Esther Olunu
Journal:  Open Access Maced J Med Sci       Date:  2018-03-28

2.  Case report on alimentary tract hemorrhage and liver injury after therapy with oseltamivir: A case report.

Authors:  Shengbo Fang; Lingli Qi; Na Zhou; Chunyan Li
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

Review 3.  Oseltamivir in seasonal, pandemic, and avian influenza: a comprehensive review of 10-years clinical experience.

Authors:  James R Smith; Craig R Rayner; Barbara Donner; Martina Wollenhaupt; Klaus Klumpp; Regina Dutkowski
Journal:  Adv Ther       Date:  2011-11-01       Impact factor: 3.845
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.